Barely Significant
← all excerpts

Efficacy of Subconjunctivally Applied Everolimus- and Sirolimus-Pretreated MSCs in Preventing Diabetic Retinopathy.

Transl Vis Sci Technol · 2025 · PMC12442941 · PMID 40952054

3
hedged sentences
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

did not reach statistical significanceP = 0.057so close (0.05 < p ≤ 0.1)
This indicates a potential benefit of everolimus pretreatment in preserving cone–bipolar pathway function, although the difference did not reach statistical significance in our analysis ( P = 0.057).

also in 111,027 other papers

a nonsignificant trendno p-value reported
Although everolimus showed a nonsignificant trend toward better flicker ERG outcomes, both pretreatment strategies similarly protected the outer retinal layers histologically, without a significant difference between them.

also in 5,406 other papers

showed a trendno p-value reported
The MSC-E group exhibited significantly higher amplitudes than the DM group ( P < 0.001) and showed a trend toward higher amplitudes compared to the MSC and MSC-S groups, although these differences were not statistically significant ( P = 0.066 and 0.057, respectively) ( Fig. 5 b).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.